# Via Nova Therapeutics, Inc. — Form D

Via Nova Therapeutics, Inc. of OAKLAND, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-15. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-09-15
- Form: D
- Accession: 0001882697-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 2
- Date of first sale: 2021-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413505

## Issuer

- Name: Via Nova Therapeutics, Inc.
- CIK: 0001882697
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1111 BROADWAY, OAKLAND, CA, 94607
- Phone: 510-227-2102

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Donald Ganem | Director | OAKLAND, CA |
| Joseph Jimenez | Director | Oakland, CA |
| Benjamine Liu | Director | New York, NY |
| Ilan Zipkin | Director | OAKLAND, CA |
| Donald Ganem | Executive Officer | OAKLAND, CA |

## More

- [CIK 1882697 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1882697&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001882697-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.